Richard M. Murray is the Thomas E. and Doris Everhart Professor of Control and Dynamical Systems and Bioengineering at the California Institute of Technology (Caltech). He holds a B.S. from Caltech (1985), M.S. from UC Berkeley (1988), and Ph.D. from UC Berkeley (1990). He has served in academic roles from Assistant Professor (1991–1997) to his current endowed professorship. He chaired the Engineering and Applied Science division (2000–2005) and Biology and Biological Engineering (2020–2024). His research focuses on feedback control in biological and autonomous systems, synthetic cells, and networked control systems. Collaborators include experts in robotics, synthetic biology, and systems biology. Key awards include the IEEE Control Systems Award and election to the National Academy of Engineering. His educational contributions span courses on control systems, robotics, and bioengineering. Current research projects include the Developer Cell initiative (Sloan Foundation), layered testing for autonomous systems (AFOSR), and microbiome-based environmental solutions (CHARMME, ARO). He advises numerous graduate students and postdocs, with notable alumni in academia and industry. Labs include facilities in Keck and Steele laboratories at Caltech. His work bridges control theory, synthetic biology, and autonomous systems to address societal challenges like environmental monitoring and safe autonomy.
Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.
Katja Hose is a Full Professor of Data Management at TU Wien's DBAI research unit, heading the Data Management and Knowledge-Driven AI Lab. She previously held a Poul Due Jensen Foundation Professorship at Aalborg University. Her research focuses on data and knowledge engineering, including graph databases, knowledge graphs, querying, analytics, and machine learning, with interdisciplinary applications in bioscience, healthcare, and environmental assessment. Education: PhD in Computer Science (Ilmenau University of Technology, 2009), Postdoc at Max Planck Institute for Informatics (2009–2012). Academic roles include Program Co-Chair for ISWC 2024 and EDBT 2023, and editorial board membership at VLDBJ and TGDK. She leads projects like TARGET (health virtual twins) and ARMADA (data management). Research Interests: Knowledge Graphs, Semantic Web, Big Data, Machine Learning, Data Integration, and Provenance Systems. Key contributions include SHACL shape extraction, conversational data analytics, and environmental knowledge graphs. Awards include the 2025 Distinguished Meta-Reviewer Award and 2024 Manfred Paul Award. Advising and Grants: Supervised students including E. Pürmayr (Diploma Thesis 2025). Active in EU projects (TARGET, ARMADA) and grant coordination. Labs/Teams: DMKI Lab at TU Wien, collaborating with interdisciplinary teams in healthcare and environmental science.
Wing Lam is an Associate Research Scientist in the Department of Pharmacology at the Yale School of Medicine. He holds a BSc in Molecular Biology and a PhD in Biochemical Pharmacology from City University of Hong Kong, followed by postdoctoral training at Yale. His research focuses on developing traditional Chinese medicine (TCM) formulations as adjuvants for cancer therapy, notably YIV-906, which enhances chemotherapy efficacy and mitigates intestinal toxicity. Lam also pioneered the STAR database for herbal drug discovery and the Mechanism-Based Quality Control (MBQC) platform for botanical drug standardization. Education: BSc (Hons) Molecular Biology, City University of Hong Kong, 1995 PhD Biochemical Pharmacology, City University of Hong Kong, 1999 Postdoc, Pharmacology, Yale University, 1999-2002 His research interests span cancer pharmacology, TCM modernization, and mitochondrial toxicity mechanisms. Key projects include YIV-906’s role in enhancing anti-PD1 and CAR T-cell therapies, developing L-nucleoside analogs like troxacitabine, and investigating tylophorine analogs’ antitumor effects. Lam has co-chaired sessions at multiple Consortium for Globalization of Chinese Medicine (CGCM) meetings and contributed to patents on herbal drug formulations and quality control methods. Recent work explores YIV-906’s potential for inflammatory bowel disease (IBD) and phase II clinical trials for colon and liver cancers. Lam’s publications highlight synergistic drug interactions, mitochondrial DNA depletion mechanisms, and TCM’s evidence-based application in chronic diseases. His grants include studies on PHY906 as an adjuvant in rectal cancer therapy and collaborations with Yiviva, Inc. He maintains active roles in editorial boards, including a special issue on herbal drug quality control in Frontiers in Pharmacology . Lam’s lab is embedded within Dr. Yung-Chi Cheng’s group, focusing on translational pharmacology and botanical drug innovation.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Lauren Andrews serves as Associate Professor and Marvin and Eva Schlanger Faculty Fellow in the Department of Chemical Engineering at the University of Massachusetts Amherst. Her research integrates synthetic biology and genetic engineering to develop programmable cellular systems for biotechnological applications. Education: Postdoctoral Training: Massachusetts Institute of Technology (Biological Engineering and Broad Institute of MIT and Harvard) PhD: University of Colorado Boulder, Chemical Engineering (2012) MS: University of Colorado Boulder, Chemical Engineering (2009) BS: Cornell University, Chemical Engineering (2006) Dr. Andrews' research focuses on establishing genetic design rules for reprogramming cellular regulation and metabolism. Her lab pioneers synthetic gene networks, genetically-encoded biosensors, and high-throughput methodologies for optimizing genetic designs in both model and non-model bacteria. This work enables precise control of cellular sensing, memory, and environmental responses through multiplexed DNA assembly and next-generation sequencing. Analysis of her 15 most recent publications reveals dominant themes in bacterial biosensor development (particularly for bioremediation), quorum sensing engineering, and programmable genetic circuits for probiotic applications. Her research consistently bridges fundamental genetic circuit design with practical implementations in bacterial consortia and non-model organisms. Scientific Awards: Marvin and Eva Schlanger Faculty Fellowship NSF CAREER Award (2020) for "Programmable synthetic microbial consortia for complex multicellular functions" Her grant portfolio demonstrates significant funding for collaborative research in bacterial communication systems and model-guided design of synthetic ecosystems. The Andrews Lab maintains active partnerships with the MIT-Broad Foundry and Cold Spring Harbor Laboratory, where she co-founded the Synthetic Biology Summer Course. Current projects focus on CRISPR-based regulation in non-model bacteria and algorithmic programming of sequential logic in probiotic strains. The Andrews Lab operates within the Life Science Laboratories at UMass Amherst, utilizing advanced facilities for genetic prototyping and high-throughput screening. Her team develops multiplexed tools for exploring genetic design spaces, with particular emphasis on soil bacteria and Gram-positive pathogens for environmental and therapeutic applications.
Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .
Rahul Sarpeshkar is a Professor of Engineering, Microbiology & Immunology, Physics, and Molecular & Systems Biology at Dartmouth College, holding the Thomas E. Kurtz Professorship and chairing the Neukom Computational Science Cluster. His research bridges analog circuits with quantum physics, synthetic biology, and ultra-low-power systems. BS in Electrical Engineering and Physics from MIT (1995) PhD in Computation and Neural Systems from Caltech (1998) His research focuses on analog synthetic biology , quantum circuit design , and bio-inspired supercomputing , emphasizing noise, thermodynamics, and energy efficiency. He develops cytomorphic chips to model biochemical networks and quantum-inspired circuits for spectrum analysis. Recent work integrates quantum and classical computation for biological simulations, drug cocktail formulation , and ATP energy measurement in living cells. Patents highlight innovations in quantum emulation and medical devices. Scientific awards include: Fellow, National Academy of Inventors (2018) IEEE Fellow (2018) NSF CAREER Award ONR Young Investigator Award Packard Fellow Award Junior Bose Teaching Award, MIT He leads a wet lab for synthetic microbial circuit implementation and a dry lab for quantum and nanoelectronics, mentoring a multidisciplinary team of physicists, bioengineers, and computer scientists.
Elin Org is a Professor of Microbiomics at the University of Tartu's Institute of Genomics, where she also serves as Head of the Estonian Genome Centre and Vice Director of the Institute. Her academic career spans over two decades with significant contributions to microbiome and genomic research. Education: PhD in Genetics, University of Tartu (2006) Master's Degree in Molecular Biotechnology and Biomedicine, University of Tartu (2000) Bachelor's Degree, University of Tartu (1997) Classical Singing, Heino Eller Tartu Music School (1996) Professor Org's research primarily focuses on the intricate relationships between host and gut microbiota and their influence on metabolism and common complex diseases. Her work bridges microbiomics, genomics, and complex disease research, with particular emphasis on understanding how gut microbiome composition affects human health. She has pioneered research connecting long-term antibiotic usage with microbiota-dependent effects and has made significant contributions to understanding the role of gut microbiome in conditions such as gestational diabetes, endometriosis, and polycystic ovary syndrome. Her approach integrates advanced computational methods with comprehensive health data to uncover causal relationships in microbiome research. Her recent publications demonstrate a strong trend toward integrating microbiome data with extensive digital health metrics, using machine learning approaches to identify microbial predictors of health outcomes. This work is increasingly focused on translating microbiome research into clinical applications for disease prediction and personalized medicine approaches, particularly in the context of the Estonian Biobank initiative. Major Scientific Recognition: 2025 National Science Award in medical and health sciences 2023 and 2022: Recognized among the world's top 1% most cited researchers by Clarivate Analytics 2020: Member of AcademiaNet, a portal for top female researchers 2017: EMBO Installation grant 2013: Marie Curie International Outgoing Fellowship Professor Org has secured substantial research funding as principal investigator for multiple significant projects, including 'DISCERN - Discovering the causes of three poorly understood cancers in Europe' (€245,466, European Commission) and 'Improving colorectal cancer screening and prediction using microbiome-based biomarkers' (€760,450, Estonian Research Council). She has served as an opponent for numerous PhD theses across European institutions, contributing to the development of emerging researchers in her field. As Head of the Estonian Genome Centre, Professor Org leads a multidisciplinary research team that plays a crucial role in Estonia's transition from biobanking to personalized medicine applications. She is actively involved in international collaborations through COST networks including INFOGUT (focused on in vitro colon models) and ML4Microbiome (statistical and machine learning techniques in human microbiome studies), positioning her at the forefront of global microbiome research initiatives.
Dr. Xi Chen is a Professor in the Department of Chemistry at the University of California, Davis, where he has been a faculty member since 2003. His research spans carbohydrate chemistry, glycobiology, and cancer biology, with notable contributions to chemoenzymatic methods for glycoconjugate synthesis. Dr. Chen's work focuses on developing hybrid chemical-enzymatic approaches to synthesize complex carbohydrates and glycoconjugates, characterizing glycosyltransferase mechanisms, and designing enzyme mutants for improved catalysis. He also investigates carbohydrate-based diagnostics and therapeutics, particularly in cancer and inflammatory diseases. His recent publications highlight interdisciplinary studies linking carbohydrate metabolism to p53 tumor suppression pathways and RNA-binding protein regulation in cancer. Awards include AAAS Fellow (2015), ACS Isbell Award (2012), and NSF CAREER Award (2006). He earned his Ph.D. at Wayne State University (2000) and B.S. at Xiamen University (1994). Scientific Awards American Association for the Advancement of Science Fellow (2015) Dean's Team Award for Excellence (2013) Carbohydrate Research Award for Creativity (2013) ACS CARB Horace S. Isbell Award (2012)
Prof. Dr. Urs F. Greber is an Ordinary Professor of Molecular Cell Biology at the Department of Molecular Life Sciences, Faculty of Mathematics and Natural Sciences, University of Zurich. His research focuses on understanding how viruses interact with host cells, particularly adenoviruses and rhinoviruses that cause human respiratory diseases. He leads the Greber Lab, which investigates viral entry mechanisms, replication processes, and the cellular responses to infection. Greber's research interests span virology, molecular cell biology, and infection mechanisms. His lab explores how viruses take control over membrane and lipid functions, cytoplasmic transport processes, and cellular metabolism to support their gene expression and progeny formation. They employ system-wide profiling, molecular cell biology approaches, light microscopy, and machine learning for image analysis to map the cell state underlying viral infections of cultured and primary human cells, including lung organoids and iPSC-derived macrophages. A key focus is understanding cell-to-cell variability in infection phenotypes and the mode-of-action of antiviral compounds. The Greber Lab has published extensively on adenovirus biology, including viral entry, uncoating, nuclear import, and assembly mechanisms. Their recent work has identified broad-spectrum antiviral compounds, elucidated alternative virus entry pathways, and developed innovative imaging and AI-based approaches for quantifying virus infectivity. Their research contributes to understanding how viruses break down host defense barriers and has implications for antiviral therapy development. Greber has supervised numerous PhD and Master's students including Cornelia Bircher, Alessandro Savi, Franziska Tomas, Alfonso Gomez-Gonzalez, Anthony Petkidis, and Dominik Olszewski. His lab has received funding from the Swiss National Science Foundation, including a grant for coronavirus research during the pandemic. The lab actively collaborates with other research groups at University of Zurich, ETH Zurich, and international institutions. Current projects include exploring how viral DNA interactions contribute to infection outcome variability, investigating adenovirus egress mechanisms, and developing high-throughput screening methods for antiviral compounds.
Ferran Garcia-Pichel is a Regents Professor and Center Director at Arizona State University’s School of Life Sciences, affiliated with the Biodesign Center for Fundamental & Applied Microbiomics, Center for Biodiversity Outcomes, Water Institute, and Global Drylands Center. He holds a PhD in Microbiology from the University of Oregon (1999) and has been a faculty member at ASU since 1999. His research focuses on microbial adaptations in arid environments, including biogeochemical cycling, soil crust formation, and sustainable land restoration. Key interests include cyanobacterial sunscreen compounds (scytonemin), carbonate dissolution mechanisms, and hydrogen production. Teaching responsibilities include advanced microbiology, microbial ecology, and geomicrobiology courses such as MBB 495 Undergraduate Research and BIO 493 Honors Thesis. Awards span from the 2021 Regents Professor distinction to the 2023 Sperry Award for restoration science. His lab explores interdisciplinary approaches to study microbial communities in desert soils, marine intertidals, and atmospheric dust, with applications in climate resilience and biomedicine. Research highlights include biocrust restoration strategies, microbial nitrogen fixation networks, and the role of GABA/Glu signaling in spatial organization. Collaborations address global challenges like fugitive dust mitigation and carbon sequestration. The lab is based at the Biodesign Building B on ASU’s Tempe campus.
Vijini Mallawaarachchi is a Research Fellow in Bioinformatics at Flinders University's Flinders Accelerator for Microbiome Exploration (FAME). His research focuses on developing computational methods for metagenomic analysis, particularly viral genome recovery from metagenomes. He holds a PhD in Computer Science from the Australian National University (2022) and a BSc in Computer Science and Engineering (Honours) from the University of Moratuwa, Sri Lanka (2018). Education: Doctor of Philosophy (Computer Science), Australian National University, 2018–2022 Bachelor of Science (Computer Science & Engineering, Honours), University of Moratuwa, 2014–2018 Research Interests: Metagenomics, algorithms for genome recovery, bacteriophage discovery, machine learning applications in bioinformatics, and software engineering for computational biology. His work emphasizes leveraging assembly graphs and computational models to analyze microbial communities and viral genomes. Grants & Awards: 2025: National Computational Merit Allocation Scheme Grant (Co-CI) - A$412,000 2025: ARC Discovery Projects Grant (Co-CI) - A$685,781 2024: Outstanding PhD Thesis Award (ABACBS) 2023: Australian Society for Microbiology Early Career Award Professional Engagement: Active member of ISMB, ISVM, ACM, IEEE, ABACBS, ASM, and RSE AU/NZ. Supervises HDR and Honours students in bioinformatics and computational biology. Labs & Tools: Leads projects at FAME, developed tools like GraphBin, Phables, and ConDiGA for metagenomic analysis. Collaborates on open-source initiatives like the cogent3 Python APIs.
Ross Thyer is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at Rice University. He holds a BSc (Hons) from the University of Western Australia and a PhD from the Harry Perkins Institute of Medical Research under Drs. Rackham and Filipovska. His postdoctoral training at the University of Texas at Austin with Prof. Andrew Ellington focused on engineered biosynthesis pathways and non-canonical amino acids. He co-founded GRO Biosciences, a Boston-based biotech startup, and leads the Thyer Lab at Rice. His research bridges synthetic biology, protein engineering, and molecular programming to address global challenges. Key areas include expanding genetic codes for therapeutics, engineering biosynthetic pathways via genetic circuitry, and developing microbial systems for environmental bioremediation. Core technologies include deep learning for protein design, modular DNA assembly, and high-throughput selections. The lab also develops tools like MutCompute for enzyme engineering and domesticates non-model bacteria for bioproduction. His work emphasizes technology innovation, with recent advances in selenocysteine incorporation, L-DOPA sensing systems, and actinobacteria toolkits. The Thyer Lab actively collaborates on biocatalyst development and translational applications in healthcare and industry.
Mahipal Singh is a Professor of Animal Biotechnology and Coordinator of the Animal Science Undergraduate Program at Fort Valley State University (FVSU), where he is affiliated with the College of Agriculture, Family Sciences and Technology and the Department of Agricultural Sciences. He has been at FVSU since 2000 in various capacities, progressing from Adjunct Biology/MPH Graduate Faculty to his current position as full Professor since 2019. Dr. Singh earned his educational credentials in India: a B.S. (Hons) in Zoology from Meerut College (1978), an M.S. in Zoology from the Institute of Advanced Studies, Meerut University (1983), and a Ph.D. in Zoology-Microbiology from Banaras Hindu University, Varanasi (1989). His academic journey included prestigious appointments such as International Visiting Fellow at the National Institute of Child Health and Human Development, NIH (1991-1993) and Postdoctoral Fellow at the Medical University of South Carolina (1989-1991). His research focuses on cutting-edge areas of animal biotechnology, particularly in postmortem cell recovery, genome editing in livestock, and myostatin gene targeting. Dr. Singh has pioneered work demonstrating that individual cells remain viable in mammalian tissues for much longer periods after death than previously believed, with applications for cellular therapies and germplasm preservation. His work with CRISPR/Cas technology aims to reduce milk allergens and mastitis in goats, while his myostatin research seeks to enhance muscular mass in meat goats for agricultural applications. Analysis of his recent publications reveals a consistent focus on cellular viability after death across multiple livestock species (cattle, goats, sheep), with particular attention to temperature effects and storage conditions. His work bridges basic cellular biology with practical agricultural applications, demonstrating how fundamental discoveries about postmortem cellular life can translate into biotechnological advances for livestock preservation and improvement. USDA-ARS 1890 Faculty Research Fellowship Award (2017) STEM Research Excellence Award, Fort Valley State University (2014-15) Multiple student research presentation awards at FVSU Annual Research Day symposiums Best Poster Award at National Symposium on Biotechnology, CIMAP, Lucknow, India (1999) Fogarty International Visiting Fellowship at NIH (1991-93) Dr. Singh has supervised an impressive 38 students across multiple educational levels, including 4 PhD, 13 MS, 7 BS, 8 HS, and 6 middle school students. His research has been supported by USDA-ARS, USDA-NIFA programs, and various other grants. He serves on multiple editorial boards, grant review panels, and university committees, and is an active member of professional societies including the American Society of Animal Science and Society for In Vitro Biology. Based in the Stallworth Biotechnology Building at FVSU, Dr. Singh leads research projects that bridge molecular biology with practical agricultural applications, working collaboratively with researchers from USDA-ARS, University of Illinois, University of Maryland, and other institutions to advance animal biotechnology and improve livestock production systems.
